Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP180396.RA8H9gzTZugKT_lviYiTsC2WBcpNECnTgt8fj_UCY-B5Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP180396.RA8H9gzTZugKT_lviYiTsC2WBcpNECnTgt8fj_UCY-B5Y130_assertion type Assertion NP180396.RA8H9gzTZugKT_lviYiTsC2WBcpNECnTgt8fj_UCY-B5Y130_head.
- NP180396.RA8H9gzTZugKT_lviYiTsC2WBcpNECnTgt8fj_UCY-B5Y130_assertion description "[Moderately intensive warfarin therapy (international normalized ratio 2.0-3.0) could generally reduce the frequency of recurrent thrombotic events by at least 2-fold as compared with that before warfarin administration. The efficiency of using warfarin al]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP180396.RA8H9gzTZugKT_lviYiTsC2WBcpNECnTgt8fj_UCY-B5Y130_provenance.
- NP180396.RA8H9gzTZugKT_lviYiTsC2WBcpNECnTgt8fj_UCY-B5Y130_assertion evidence source_evidence_literature NP180396.RA8H9gzTZugKT_lviYiTsC2WBcpNECnTgt8fj_UCY-B5Y130_provenance.
- NP180396.RA8H9gzTZugKT_lviYiTsC2WBcpNECnTgt8fj_UCY-B5Y130_assertion SIO_000772 20597268 NP180396.RA8H9gzTZugKT_lviYiTsC2WBcpNECnTgt8fj_UCY-B5Y130_provenance.
- NP180396.RA8H9gzTZugKT_lviYiTsC2WBcpNECnTgt8fj_UCY-B5Y130_assertion wasDerivedFrom gad-20150221 NP180396.RA8H9gzTZugKT_lviYiTsC2WBcpNECnTgt8fj_UCY-B5Y130_provenance.
- NP180396.RA8H9gzTZugKT_lviYiTsC2WBcpNECnTgt8fj_UCY-B5Y130_assertion wasGeneratedBy ECO_0000203 NP180396.RA8H9gzTZugKT_lviYiTsC2WBcpNECnTgt8fj_UCY-B5Y130_provenance.